Massivemarkets

Nasdaq: RTSN · Listed Oct 9, 2026

Retension Pharmaceuticals IPO

$13.89

▲ +21.73%today · +15.75% since the $12.00 IPO price

15-minute delayed · as of 7:30:03 PM EST on Nov 18, 2026

Retension Pharmaceuticals (RTSN) priced its IPO at $12.00 a share and has traded on Nasdaq since Oct 9, 2026.

Last session · Nov 18, 2026

VWAP 12.90open 11.45high 13.70$13.40volume · rising bars above the line, falling bars below7.13K9:404:00
Market cap
$115.73M
from the ticker reference
Volume
104.06K
shares, regular session
VWAP
$12.90
the last price is +7.67% from the volume-weighted average
Day range
11.45–14.16
low to high

The trading numbers are from the last session, Nov 18, 2026.

The debut race

RTSN against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%RTSN +11.71%

The IPO scoreboard

RTSN against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

RTSN against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Retension Pharmaceuticals '26$45M-16.67%-8.17%+3.33%Not yet
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Retension Pharmaceuticals IPO offers 3.75M shares to raise $45M, before any underwriters' option.

$9$11$12$13$15
Expected price range
$11 to $13
IPO price
$12.00
Shares offered
3.75M
Money raised
$45M
Listing date
Oct 9, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Retension Pharmaceuticals$45M

Where RTSN ranks

Retension Pharmaceuticals's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • RTSN$115.73M

What comes after the IPO

Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.

  1. Oct 9, 2026

    First trade

    Prices, bars, and snapshots

  2. Oct 14, 2026 · est.

    Options list

    Option chain and open interest

  3. Oct 29, 2026 · est.

    First short interest

    Short interest and daily short volume

  4. Nov 3, 2026 · est.

    Quiet period ends

    Analyst ratings and price targets

  5. Feb 14, 2027

    First 13F deadline

    Which funds hold the stock

  6. Date not set

    First earnings

    Income statement and ratios

  7. Apr 6, 2027 · est.

    Lock-up expires

    Insider sales on Form 4

Filings and the company

What Retension Pharmaceuticals has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Retension Pharmaceuticals discloses to the SEC on Form 8-K.

  • Quarterly earningsNov 18, 2026

    On November 18, 2026, Retension Pharmaceuticals, Inc. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026.

  • Executive compensation changeOct 23, 2026

    The Company and Mr. Wong entered into an Offer Letter establishing the terms of Mr. Wong's employment with the Company, which provides for an annual base salary of $360,000, eligibility for a discretionary bonus with a target opportunity equal to 30% of his base salary, and a sign-on bonus of $20,000.

  • Charter amendmentOct 13, 2026

    In connection with the closing of the Company's initial public offering (the "IPO") on October 13, 2026, the Company filed its Third Amended and Restated Certificate of Incorporation (the "Amended and Restated Certificate") with the Secretary of State of the State of Delaware on October 9, 2026. The Company's board of directors (the "Board") and stockholders previously approved the Amended and Restated Certificate to be filed in connection with, and become effective immediately prior to, the closing of the IPO.

About Retension Pharmaceuticals

Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.

Ticker
RTSN
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
PHARMACEUTICAL PREPARATIONS
Listed
Oct 9, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Retension Pharmaceuticals IPO price?

$12.00 a share.

When did Retension Pharmaceuticals go public?

Retension Pharmaceuticals listed on Nasdaq on Oct 9, 2026 under the ticker RTSN.

How much did the Retension Pharmaceuticals IPO raise?

$45M, before any underwriters' option.

How did Retension Pharmaceuticals open on its first day?

RTSN first traded at $10.00, -16.67% from the IPO price of $12.00.

How did RTSN close on its first day?

Its last regular-session trade was $11.02, -8.17% from the IPO price of $12.00.

What was the RTSN first-day trading range?

$9.66 to $11.60 in the regular session.

How many RTSN shares traded on the first day?

723.79K shares in the regular session.

How many shares did Retension Pharmaceuticals sell in its IPO?

3.75M shares.

What exchange is RTSN listed on?

Retension Pharmaceuticals lists on Nasdaq under the ticker RTSN.

Are the prices on this page real time?

No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.

Build with Massive

Get the RTSN data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/RTSN/range/5/minute
Market cap/v3/reference/tickers/RTSN
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.